Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02246400 · ClinicalTrials.gov registry record · NA

CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact

A NA study, sponsored by Palo Alto Medical Foundation.

Completed
Registry status
NA
Development phase
74
Enrollment target

NCT02246400: Completed NA study, sponsored by Palo Alto Medical Foundation.

NCT02246400 is a NA study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02246400, a NA study, has completed, sponsored by Palo Alto Medical Foundation.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

The eCMP Pilot aims to study the feasibility and potential effectiveness of an electronically-mediated CardioMetabolic Program (eCMP) for therapeutic lifestyle change among adults with or at high risk for type 2 diabetes, heart disease, and/or stroke.

Primary Outcome

SF-8 questionnaire

Interventions

  • BEHAVIORAL eCMP

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2014-01
Est. Completion 2014-12
Phase NA
Palo Alto Medical Foundation

11 total trials

What the finished NCT02246400 record still lists

NCT02246400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which eCMP is the first listed.

NCT02246400 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02246400 about?

NCT02246400 is a clinical study titled "CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact". The eCMP Pilot aims to study the feasibility and potential effectiveness of an electronically-mediated CardioMetabolic Program (eCMP) for therapeutic lifestyle change among adults with or at high risk for type 2 diabetes, heart disease, and/or stroke.

What is the current status of trial NCT02246400?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2014-01. Estimated completion is 2014-12.

What interventions are being tested in trial NCT02246400?

The interventions under investigation include: eCMP (BEHAVIORAL).

Who is sponsoring clinical trial NCT02246400?

This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02246400's enrollment target sits among peer trials

74 1082nd of 2000 higher than 912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02246400, the US trial registry maintained by the National Library of Medicine. NCT02246400 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.